Discovery of a novel third generation EGFR TKI and identification of its potential mechanism of resistance
文献类型：期刊论文
| 作者 | Zhang, Tao1; Qu, Rong1; Chen, Chengbin2; Tong, Linjiang1; Feng, Fang1; Chen, Yi1 ; Geng, Meiyu1; Ding, Ke2; Xie, Hua1; Ding, Jian1
|
| 刊名 | CANCER RESEARCH
 |
| 出版日期 | 2019-07-01 |
| 卷号 | 79期号:13页码:2 |
| ISSN号 | 0008-5472 |
| DOI | 10.1158/1538-7445.AM2019-2210 |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000488279400205 |
| 出版者 | AMER ASSOC CANCER RESEARCH |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/282720]  |
| 专题 | 中国科学院上海药物研究所 |
| 作者单位 | 1.Shanghai Inst Mat Med, Shanghai, Peoples R China 2.Jinan Univ, Sch Pharm, Guangzhou, Guangdong, Peoples R China |
| 推荐引用方式 GB/T 7714 | Zhang, Tao,Qu, Rong,Chen, Chengbin,et al. Discovery of a novel third generation EGFR TKI and identification of its potential mechanism of resistance[J]. CANCER RESEARCH,2019,79(13):2. |
| APA | Zhang, Tao.,Qu, Rong.,Chen, Chengbin.,Tong, Linjiang.,Feng, Fang.,...&Ding, Jian.(2019).Discovery of a novel third generation EGFR TKI and identification of its potential mechanism of resistance.CANCER RESEARCH,79(13),2. |
| MLA | Zhang, Tao,et al."Discovery of a novel third generation EGFR TKI and identification of its potential mechanism of resistance".CANCER RESEARCH 79.13(2019):2. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。